By: New York Times | Washington | Updated: December 8, 2020 9:10:37 pm The finding is one of several important new results presented in the informational materials, which span 53 pages of analysis of data from the agency and Pfizer. The coronavirus vaccine manufactured by Pfizer and BioNTech provides strong …
Read More »
Russia announced on Tuesday the results of the second interim analysis of data from the Sputnik V Covid-19 vaccine clinical trial, which showed greater than 95% efficacy 42 days after the first dose. Kirill Dmitriev, head of Russia’s RDIF sovereign wealth fund, said that new clinical trial data based on …
Read More »
By the end of this month, more than a million people could die from Covid worldwide. Economies are reeling from the impact of physical distancing measures. A vaccine is urgently needed to save lives and livelihoods, and some of the dozens of vaccines in development, such as Russia’s Sputnik V, …
Read More »
MOSCOW: The COVID-19 vaccine, Sputnik V, approved by Russia last month, has been shown to elicit an antibody response without serious adverse events in small human trials, according to preliminary results published in The Lancet on Friday. Results from early phase non-randomized vaccine trials in a total of 76 people …
Read More »